CWGCX
Price
$76.26
Change
+$0.53 (+0.70%)
Updated
Dec 3 closing price
Net Assets
142.32B
NUGCX
Price
$37.65
Change
+$0.19 (+0.51%)
Updated
Dec 3 closing price
Net Assets
17.33M
Interact to see
Advertisement

CWGCX vs NUGCX

Header iconCWGCX vs NUGCX Comparison
Open Charts CWGCX vs NUGCXBanner chart's image
American Funds Capital World Gr&Inc C
Price$76.26
Change+$0.53 (+0.70%)
VolumeN/A
Net Assets142.32B
Nuveen Global Dividend Growth C
Price$37.65
Change+$0.19 (+0.51%)
VolumeN/A
Net Assets17.33M
CWGCX vs NUGCX Comparison Chart in %
View a ticker or compare two or three
VS
CWGCX vs. NUGCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and NUGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 142B vs. NUGCX (17.3M). CWGCX pays higher dividends than NUGCX: CWGCX (0.75) vs NUGCX (0.43). CWGCX was incepted earlier than NUGCX: CWGCX (25 years) vs NUGCX (13 years). NUGCX (2.58) is less costly to investors than CWGCX (1.49). CWGCX is a more actively managed with annual turnover of: 27.00 vs. NUGCX (17.00). CWGCX has a lower initial minimum investment than NUGCX: CWGCX (250) vs NUGCX (2500). CWGCX annual gain was more profitable for investors over the last year : 11.77 vs. NUGCX (0.62). CWGCX return over 5 years is better than : 37.40 vs. NUGCX (33.62).
CWGCXNUGCXCWGCX / NUGCX
Total Expense Ratio1.491.9078%
Annual Report Gross Expense Ratio1.492.5858%
Fund Existence25 years13 years-
Gain YTD21.2379.555222%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets142B17.3M820,809%
Annual Yield % from dividends0.750.43173%
Returns for 1 year11.770.621,902%
Returns for 3 years46.4326.01179%
Returns for 5 years37.4033.62111%
Returns for 10 years74.7254.03138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANTX1.080.03
+2.86%
AN2 Therapeutics
CDNS317.858.23
+2.66%
Cadence Design Systems
SBR78.25-0.44
-0.56%
Sabine Royalty Trust
HRB41.94-0.30
-0.71%
H&R Block
AVIR3.01-0.09
-2.75%
Atea Pharmaceuticals